1. Home
  2. TEVA vs OC Comparison

TEVA vs OC Comparison

Compare TEVA & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • OC
  • Stock Information
  • Founded
  • TEVA 1901
  • OC 1938
  • Country
  • TEVA Israel
  • OC United States
  • Employees
  • TEVA N/A
  • OC N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • OC Industrial Machinery/Components
  • Sector
  • TEVA Health Care
  • OC Industrials
  • Exchange
  • TEVA Nasdaq
  • OC Nasdaq
  • Market Cap
  • TEVA 19.2B
  • OC 16.9B
  • IPO Year
  • TEVA N/A
  • OC N/A
  • Fundamental
  • Price
  • TEVA $21.94
  • OC $169.17
  • Analyst Decision
  • TEVA Buy
  • OC Buy
  • Analyst Count
  • TEVA 7
  • OC 13
  • Target Price
  • TEVA $21.00
  • OC $200.83
  • AVG Volume (30 Days)
  • TEVA 11.9M
  • OC 1.1M
  • Earning Date
  • TEVA 01-29-2025
  • OC 02-12-2025
  • Dividend Yield
  • TEVA N/A
  • OC 1.63%
  • EPS Growth
  • TEVA N/A
  • OC N/A
  • EPS
  • TEVA N/A
  • OC 11.72
  • Revenue
  • TEVA $16,772,000,000.00
  • OC $10,439,000,000.00
  • Revenue This Year
  • TEVA $4.70
  • OC $16.55
  • Revenue Next Year
  • TEVA $4.47
  • OC $8.90
  • P/E Ratio
  • TEVA N/A
  • OC $14.46
  • Revenue Growth
  • TEVA 9.81
  • OC 8.09
  • 52 Week Low
  • TEVA $10.34
  • OC $138.70
  • 52 Week High
  • TEVA $22.17
  • OC $214.53
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 75.93
  • OC 24.42
  • Support Level
  • TEVA $16.25
  • OC $194.80
  • Resistance Level
  • TEVA $21.98
  • OC $185.93
  • Average True Range (ATR)
  • TEVA 0.79
  • OC 4.84
  • MACD
  • TEVA 0.53
  • OC -4.18
  • Stochastic Oscillator
  • TEVA 90.58
  • OC 2.56

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About OC Owens Corning Inc New

Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with three reportable segments: Composites, Insulation, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: